Ye Xu

8.1k total citations · 2 hit papers
187 papers, 5.7k citations indexed

About

Ye Xu is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Ye Xu has authored 187 papers receiving a total of 5.7k indexed citations (citations by other indexed papers that have themselves been cited), including 95 papers in Oncology, 59 papers in Molecular Biology and 50 papers in Cancer Research. Recurrent topics in Ye Xu's work include Colorectal Cancer Surgical Treatments (39 papers), Colorectal Cancer Treatments and Studies (37 papers) and Colorectal and Anal Carcinomas (32 papers). Ye Xu is often cited by papers focused on Colorectal Cancer Surgical Treatments (39 papers), Colorectal Cancer Treatments and Studies (37 papers) and Colorectal and Anal Carcinomas (32 papers). Ye Xu collaborates with scholars based in China, United States and Netherlands. Ye Xu's co-authors include Sanjun Cai, Xinxiang Li, Jun Shen, Zhihua Ran, Guoxiang Cai, Weixing Dai, Sanjun Cai, Fangqi Liu, Ping Wei and Dawei Li and has published in prestigious journals such as Chemical Society Reviews, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Ye Xu

176 papers receiving 5.6k citations

Hit Papers

Tumor-derived exosomal miR-934 induces macrophage M2 pola... 2019 2026 2021 2023 2020 2019 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ye Xu China 38 2.9k 2.2k 1.9k 804 768 187 5.7k
Muh‐Hwa Yang Taiwan 48 4.0k 1.4× 2.2k 1.0× 2.9k 1.5× 990 1.2× 852 1.1× 164 7.6k
Vivian Wai Yan Lui Hong Kong 40 3.5k 1.2× 1.7k 0.8× 2.5k 1.3× 1.1k 1.4× 568 0.7× 112 6.9k
Sanjun Cai China 35 2.6k 0.9× 1.7k 0.8× 2.4k 1.2× 815 1.0× 913 1.2× 132 5.3k
Ja Seung Koo South Korea 43 2.7k 0.9× 2.8k 1.3× 2.4k 1.2× 807 1.0× 565 0.7× 231 6.3k
Yoshinaga Okugawa Japan 43 3.5k 1.2× 2.6k 1.2× 2.5k 1.3× 939 1.2× 1.0k 1.3× 237 6.9k
Jian Zhou China 39 2.5k 0.9× 1.8k 0.8× 2.0k 1.0× 1.0k 1.3× 1.0k 1.3× 225 6.6k
Aikou Okamoto Japan 36 4.4k 1.5× 3.1k 1.4× 1.9k 1.0× 770 1.0× 754 1.0× 267 8.0k
Taiping Zhang China 40 2.7k 0.9× 2.0k 0.9× 2.7k 1.4× 791 1.0× 1.0k 1.3× 219 5.6k
Madappa N. Kundranda United States 16 2.5k 0.9× 1.5k 0.7× 2.4k 1.2× 1.4k 1.7× 901 1.2× 66 5.8k
Liang Liu China 39 2.3k 0.8× 1.7k 0.8× 2.6k 1.3× 757 0.9× 686 0.9× 165 5.3k

Countries citing papers authored by Ye Xu

Since Specialization
Citations

This map shows the geographic impact of Ye Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ye Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ye Xu more than expected).

Fields of papers citing papers by Ye Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ye Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ye Xu. The network helps show where Ye Xu may publish in the future.

Co-authorship network of co-authors of Ye Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Ye Xu. A scholar is included among the top collaborators of Ye Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ye Xu. Ye Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Wenfeng, Ye Xu, Yifan Ma, et al.. (2025). Alisertib impairs the stemness of hepatocellular carcinoma by inhibiting purine synthesis. Journal of Biological Chemistry. 301(6). 108558–108558. 1 indexed citations
3.
4.
Yu, Shaojun, Weixing Dai, Senlin Zhao, et al.. (2023). Function and mechanism of MCM8 in the development and progression of colorectal cancer. Journal of Translational Medicine. 21(1). 623–623. 6 indexed citations
5.
Zhu, Congcong, Ying Xue, Changhong Miao, et al.. (2023). A DNA methylation signature for the prediction of tumour recurrence in stage II colorectal cancer. British Journal of Cancer. 128(9). 1681–1689. 14 indexed citations
6.
Zhang, Lijie, Minghe Wang, Jing Zhang, et al.. (2023). Long-term outcomes in a retrospective cohort of patients with rectal cancer with complete response after total neoadjuvant therapy: a propensity-score weighted analysis. Therapeutic Advances in Medical Oncology. 15. 2642691–2642691. 3 indexed citations
7.
Wang, Song, Yun Xu, Tianan Guo, et al.. (2023). A one‐stop approach to diagnosing hereditary colorectal cancer in the Chinese population. Journal of Gastroenterology and Hepatology. 38(11). 1980–1987. 3 indexed citations
8.
Dai, Weixing, Wenqiang Xiang, Lingyu Han, et al.. (2022). PTPRO represses colorectal cancer tumorigenesis and progression by reprogramming fatty acid metabolism. Cancer Communications. 42(9). 848–867. 69 indexed citations
9.
Zhou, Jiamin, Long-Hai Feng, Xinxiang Li, et al.. (2022). The Value of Laparoscopic Simultaneous Colorectal and Hepatic Resection for Synchronous Colorectal Cancer Liver Metastasis: A Propensity Score Matching Study. Frontiers in Oncology. 12. 916455–916455. 3 indexed citations
10.
Zhao, Senlin, Bingjie Guan, Yushuai Mi, et al.. (2021). LncRNA MIR17HG promotes colorectal cancer liver metastasis by mediating a glycolysis-associated positive feedback circuit. Oncogene. 40(28). 4709–4724. 70 indexed citations
11.
Xu, Linguo, Lin Huan, Tianan Guo, et al.. (2020). LncRNA SNHG11 facilitates tumor metastasis by interacting with and stabilizing HIF-1α. Oncogene. 39(46). 7005–7018. 69 indexed citations
12.
Zheng, Hongtu, Yuchen Wu, Tianan Guo, et al.. (2020). Hypoxia Induces Growth Differentiation Factor 15 to Promote the Metastasis of Colorectal Cancer via PERK‐eIF2α Signaling. BioMed Research International. 2020(1). 5958272–5958272. 23 indexed citations
13.
Dai, Weixing, Ye Xu, Shaobo Mo, et al.. (2020). GLUT3 induced by AMPK/CREB1 axis is key for withstanding energy stress and augments the efficacy of current colorectal cancer therapies. Signal Transduction and Targeted Therapy. 5(1). 177–177. 90 indexed citations
14.
Wang, Sheng, Song Wang, Qin Zhang, et al.. (2019). Red-blood-cell-membrane-enveloped magnetic nanoclusters as a biomimetic theranostic nanoplatform for bimodal imaging-guided cancer photothermal therapy. Journal of Materials Chemistry B. 8(4). 803–812. 49 indexed citations
16.
Guo, Tianan, Li Xie, Jiang Zhao, et al.. (2018). [Trend analysis of morbidity and mortality of colorectal cancer in China from 1988 to 2009].. PubMed. 21(1). 33–40. 3 indexed citations
17.
Li, Qingguo, Yi Qin, Ping Wei, et al.. (2016). Gas1 Inhibits Metastatic and Metabolic Phenotypes in Colorectal Carcinoma. Molecular Cancer Research. 14(9). 830–840. 50 indexed citations
18.
Xu, Ye, Qinghua Xu, Yang Li, et al.. (2013). Identification and Validation of a Blood-Based 18-Gene Expression Signature in Colorectal Cancer. Clinical Cancer Research. 19(11). 3039–3049. 18 indexed citations
19.
Lu, Yuanming, et al.. (2012). Expression of EGFR, Her2 predict lymph node metastasis (LNM)-associated metastasis in colorectal cancer. Cancer Biomarkers. 11(5). 219–226. 35 indexed citations
20.
Xu, Ye. (2004). Health status of migrant workers in cities and policy suggestions. Zhonghua yiyuan guanli zazhi. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026